# John B. Sanfilippo & Son share price today (John B. Sanfilippo & Son, Inc., JBSS)

> John B. Sanfilippo & Son, Inc.'s P/E is near the low end of its own history, higher than only 7% of past readings, and its quarterly results are still getting worse. JBSS · Consumer Staples · Packaged Foods · data as of 3 November 2026. Page: https://www.sectoralpha.in/us/stocks/jbss

Sector Alpha also publishes a daily newsletter that explains one Indian stock at a time: https://newsletter.sectoralpha.in/?utm_source=sectoralpha&utm_medium=ai_text&utm_campaign=llms

## Key numbers

- Business trend: Slowing from a peak, from the last 12 quarters
- Price: $52.59 (−16.2% in a year)
- P/E: 11.0× (lower than 93% of the last 1 year)
- Revenue (Jun 2026): $280 M (+4.2% on a year ago)
- Profit (Jun 2026): $8.4 M (−37.9% on a year ago)
- Operating margin: 4.1% (−3.1 points on a year ago)
- ROE: 16%, FY26
- ROIC: 11.5%, against a 5.1% cost of capital: +6.4 points

The main question: the P/E is near the low end of its own history, higher than only 7% of past readings, but results are getting worse. A low multiple can stay low until the quarters turn. ## What is the John B. Sanfilippo & Son share price today? John B. Sanfilippo & Son, Inc.'s share price was $52.59 at the close on 3 November 2026. That is 31.6% below its average price over the last 200 trading days. In the last 52 weeks it traded between $53 and $91, and at that close it was at the low of that range. Over the past 13 weeks it has done worse than the S&P 500, and it has been behind for 12 weeks running. Over the last 1 year the share price moved −22% while the S&P 500 moved +21%, so it is behind the index over that whole period. It was last ahead over 13 weeks in the week of 14 August 2026. The chart above shows the 13-week comparison for every week. This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row. ## What dividend does John B. Sanfilippo & Son pay? John B. Sanfilippo & Son, Inc. has 3 quarters of declared dividends on file, too few for a 12-month total. The most recent declaration was $0.95 for Jun 2026. John B. Sanfilippo & Son, Inc. declared a dividend in 3 of the last 12 reported quarters, most recently $0.95 for Jun 2026. That is fewer than four quarters, so no 12-month total is shown. ## Which stock lists is John B. Sanfilippo & Son on? John B. Sanfilippo & Son is not in the Nasdaq 100, the S&P 500 or the Dow Jones 30, and is not on the US tech stocks list. ## Is John B. Sanfilippo & Son profitable? John B. Sanfilippo & Son, Inc. earned $8.4 M of net profit in the Jun 2026 quarter, −37.9% on the same quarter a year earlier. Full-year FY26 profit was $61.9 M. Over 5 years profit has grown 0.7% a year on average. That is 3.0% of the quarter's revenue. The same quarter a year earlier earned $13.5 M. For the full year, FY26 profit was $61.9 M (+5.1% on the year before). Why profit moved: revenue changed +4.2% on a year earlier and the margin moved −3.1 percentage points. Sales did the work while the margin got thinner. On average over the last four quarters, profit changed +9.6% and revenue +6.2%. Profit is growing faster than sales: fixed costs are spread over more sales, so each extra dollar of revenue adds more to profit. ## How much revenue does John B. Sanfilippo & Son make, and is it growing? John B. Sanfilippo & Son, Inc. reported $280 M of revenue in the Jun 2026 quarter, +4.2% on the same quarter a year earlier. That is the 4th quarter in a row with growth on the year before. Over 5 years it has grown 6.5% a year on average. The last full year, FY26, came in at $1.2 B. The last four reported quarters add to $1.2 B. FY26 revenue was $1.2 B, +6.2% on the year before. Recent pace: the last four quarters grew +6.2% on average, against 6.5% a year over the longer run, so this year is growing at about the same pace as its own long-run rate. Is growth speeding up? Revenue over the last 12 months grew +6.2%, against +5.0% a year over the last 8 quarters (stabilising); profit over the last 12 months grew +5.1%, against +1.4% a year (accelerating). ## How much of every $100 of sales does John B. Sanfilippo & Son keep? John B. Sanfilippo & Son, Inc.'s operating margin was 4.1% in the Jun 2026 quarter, 3.1 percentage points lower than the same quarter a year ago. Across 6 years it has been between 7.3% and 9.9%. The latest quarter is below every full year in that period. Why the margin moved: operating margin changed −3.1 percentage points on the year while gross margin changed −2.4 points. So the drop came mostly from the gross margin, which means input costs and prices charged. ## Is John B. Sanfilippo & Son's profit turning into cash? Over the last 3 years, 141% of John B. Sanfilippo & Son, Inc.'s reported profit came in as cash from its operations, so the profit is backed by cash. In FY26 it brought in $124 M of operating cash against $61.9 M of profit. After $88.1 M of spending on assets, $35.7 M was left over as free cash. Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year. Why: the cash figure is clear, but the day counts behind it are not in our data, so we show it without guessing the reason. What to look at next: the main use of cash is spending on assets. The next section checks what that spending is building. ## Where does John B. Sanfilippo & Son's cash go? John B. Sanfilippo & Son, Inc. does not report the customer, stock and supplier day counts a cash cycle needs, so this section looks at its spending on assets instead. It spent $167 M on assets over the last 3 years. Averaged over those years that is 4.7% of FY26 revenue a year. Nothing is estimated in place of the missing day counts, so no cash-cycle chart is drawn. Spending on assets: $167 M over the last 3 years. In short: the cash is going into new capacity, not getting stuck in the daily cycle. The question is whether the new capacity earns. ## What is John B. Sanfilippo & Son's P/E ratio, and how does it compare with its own history? John B. Sanfilippo & Son, Inc.'s P/E is 11.0×, near the low end of its own history: it has been lower only 7% of the time. Its usual P/E (the middle reading) is 13.1×, over 1 year of weekly prices. This compares the share price with the company’s own past. It does not say what the business is worth. Why the multiple is where it is: over the past year earnings per share moved +4.6% while the price moved −16.2%. Earnings did better than the price, which pulled the multiple down within its own range. In short: the multiple is low against its own past, so the earnings trend underneath matters more than the multiple. ## Is the John B. Sanfilippo & Son business getting better or worse? John B. Sanfilippo & Son, Inc.'s business is slowing from a peak. Profit and EPS growth have slowed sharply (profit growth from +21.5% at its peak to +5.1% now), while ROCE is still 18.3%. This is based on 12 quarters of 4 measures. Why it matters: slowing from a peak is where good stories often end quietly. ## How much does John B. Sanfilippo & Son earn on its capital? John B. Sanfilippo & Son, Inc. earned a ROE of 16% in FY26. Its return on capital used (ROIC) is 6.4 percentage points above its cost of capital, so growth here adds value, not just size. It comes from a 5.3% net margin and 1.79× asset turnover (sales divided by assets). Why the return is what it is (FY26): a 5.3% net margin × 1.79× asset turnover × 1.73× leverage (assets divided by equity) ≈ 16.4% on equity. The margin does its share; borrowing is a big part of it. The key test, return on capital used minus the cost of capital: 11.5% − 5.1% = +6.4 percentage points. The 5.1% is an estimate of this company's own cost of capital. Read the sign and size of the gap, not the decimals. A gap this wide means each dollar put back into the business creates more than a dollar of value. The 11.5% ROIC above is the latest reading, as reported. The yearly chart below shows FY26 at 13.4%, and the quarterly chart works out each 12-month window from the quarterly figures, so the readings differ by date, not by method. ## Does John B. Sanfilippo & Son have too much debt? John B. Sanfilippo & Son, Inc. has total debt of $109 M against shareholder equity of $380 M as of Jun 2026, so its debt is 0.29× its equity, which is very little. Year by year, that ratio went from 0.11 in FY21 to 0.29 in FY26. So the returns on this page come from the business, not from borrowed money. ## What is the John B. Sanfilippo & Son shareholding pattern? 6.3% of John B. Sanfilippo & Son, Inc.'s tradable shares are in short positions, which are bets that the price will fall, so some traders are betting against it. At normal trading volumes, closing those positions would take about 4.3 days. US companies do not publish a quarter-by-quarter list of owners, so this page uses short interest instead. It is a single reading at one point in time; we do not have its history. Why it is at this level: the figure does not say who holds the short positions or why, so we show the level without guessing the story. ## How far is John B. Sanfilippo & Son from balance-sheet trouble? For John B. Sanfilippo & Son, Inc., the Z-score is 4.63. A Z-score above about 3 is safe and below about 1.8 signals danger, so this is well clear of danger. It estimates how far the balance sheet is from trouble; it is not a forecast of failure. Why it matters: a Z-score of 4.63 is well clear of the danger zone, so the balance sheet is not the risk here. ## How does John B. Sanfilippo & Son rank in its industry? 46.3 out of 100, rank 15 of 30 in Packaged Foods, with 81% of the evidence available. John B. Sanfilippo & Son, Inc. scores 46.3 out of 100 against the 30 companies it is compared with in Packaged Foods, ranking 15. The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. The four parts add up to the total exactly: 16.1 + 16.4 + 13.5 + 0.3 = 46.3. This is the same number shown on the industry page; it is worked out once for the whole group and read here. What would change it: The score would fall if profit growth turns negative or margins stop improving while the share price lags its sector. ## Which companies is John B. Sanfilippo & Son compared with? John B. Sanfilippo & Son ranks 15 of 30 Packaged Foods companies on the 4-Factor Sector Score, with 46.3 out of 100. 1. [Seneca Foods Corporation](https://www.sectoralpha.in/us/stocks/senea) SENEA · quiet · Evidence leans up · 81% evidence 64.4 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 25.1/35 · Revenue 12.5% · Profit 100% · Operating margin change -1.2 points · 83% evidence Capital efficiency 14.2/25 · ROCE 15.2% · Operating margin 7.2% · 76% evidence Valuation 15.6/20 · P/E 9.5× · PEG 0.26 · 65% evidence Relative strength 9.5/20 · Lead over its industry 3.3% · Lead over S&P 500 -1.8% · 1 year 42.9% · 100% evidence · 5 of 12 weeks ahead Exact sum: 25.1 + 14.2 + 15.6 + 9.5 = 64.4 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 2. [The J. M. Smucker Company](https://www.sectoralpha.in/us/stocks/sjm) SJM · breaking out · Evidence leans up · 67% evidence 62.9 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 23.1/35 · Revenue 5.1% · Profit n/a · Operating margin change 14.7 points · 71% evidence Capital efficiency 13.6/25 · ROCE 12.2% · Operating margin 17.9% · 76% evidence Valuation 8.7/20 · P/E 55.5× · PEG n/a · 15% evidence Relative strength 17.5/20 · Lead over its industry 17.3% · Lead over S&P 500 10.9% · 1 year 19.5% · 100% evidence · 8 of 12 weeks ahead Exact sum: 23.1 + 13.6 + 8.7 + 17.5 = 62.9 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 3. [Westrock Coffee Company](https://www.sectoralpha.in/us/stocks/west) WEST · breaking out · Evidence leans up · 64% evidence 58.2 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 25.1/35 · Revenue 38.5% · Profit n/a · Operating margin change 5.1 points · 62% evidence Capital efficiency 3.4/25 · ROCE -0.2% · Operating margin 0.6% · 76% evidence Valuation 11.3/20 · P/E -16.3× · PEG n/a · 15% evidence Relative strength 18.4/20 · Lead over its industry 46.1% · Lead over S&P 500 40.6% · 1 year 144.7% · 100% evidence · 6 of 12 weeks ahead Exact sum: 25.1 + 3.4 + 11.3 + 18.4 = 58.2 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 4. [Central Garden & Pet Company](https://www.sectoralpha.in/us/stocks/cent) CENT · turning · Evidence leans up · 81% evidence 57.7 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 18.1/35 · Revenue -1.2% · Profit 19.4% · Operating margin change -0.2 points · 83% evidence Capital efficiency 9.9/25 · ROCE 8.2% · Operating margin 14.3% · 76% evidence Valuation 13.1/20 · P/E 15.2× · PEG 0.68 · 65% evidence Relative strength 16.6/20 · Lead over its industry 20.4% · Lead over S&P 500 14.1% · 1 year 47.5% · 100% evidence · 3 of 12 weeks ahead Exact sum: 18.1 + 9.9 + 13.1 + 16.6 = 57.7 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 5. [Herbalife Ltd.](https://www.sectoralpha.in/us/stocks/hlf) HLF · turning · Evidence leans up · 71% evidence 57.3 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 12.1/35 · Revenue 5.5% · Profit -49.4% · Operating margin change -1.1 points · 83% evidence Capital efficiency 18.5/25 · ROCE 26.8% · Operating margin 9.8% · 76% evidence Valuation 11.0/20 · P/E 6.3× · PEG n/a · 15% evidence Relative strength 15.7/20 · Lead over its industry 5.1% · Lead over S&P 500 -1.5% · 1 year 58.2% · 100% evidence · 3 of 12 weeks ahead Exact sum: 12.1 + 18.5 + 11 + 15.7 = 57.3 · What this means: Relative strength against the index is -1.5%, and revenue and profit growth are weak. 6. McCormick & Company, Incorporated MKC-V · basing · Evidence leans up · 85% evidence 53.3 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 26.3/35 · Revenue 13.2% · Profit 91.7% · Operating margin change 0.7 points · 95% evidence Capital efficiency 15.2/25 · ROCE 10.5% · Operating margin 17.8% · 76% evidence Valuation 6.8/20 · P/E 9.8× · PEG 2.64 · 65% evidence Relative strength 5.0/20 · Lead over its industry -12.9% · Lead over S&P 500 -18.6% · 1 year -25.7% · 100% evidence · 3 of 12 weeks ahead Exact sum: 26.3 + 15.2 + 6.8 + 5 = 53.3 · What this means: Earnings are strong; relative strength in its sector is -12.9% and the one-year return is -25.7%. 7. [Nomad Foods Limited](https://www.sectoralpha.in/us/stocks/nomd) NOMD · turning · Evidence leans up · 81% evidence 51.8 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 13.7/35 · Revenue -3.5% · Profit -40.8% · Operating margin change 0.1 points · 83% evidence Capital efficiency 10.4/25 · ROCE 7.3% · Operating margin 13.9% · 76% evidence Valuation 10.5/20 · P/E 10.8× · PEG 1.45 · 65% evidence Relative strength 17.2/20 · Lead over its industry 10.2% · Lead over S&P 500 3.7% · 1 year 1.1% · 100% evidence · 3 of 12 weeks ahead Exact sum: 13.7 + 10.4 + 10.5 + 17.2 = 51.8 · What this means: Relative strength against the index is 3.7%, and revenue and profit growth are weak. 8. [The Marzetti Company](https://www.sectoralpha.in/us/stocks/mzti) MZTI · basing · Evidence leans up · 81% evidence 51.7 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 17.0/35 · Revenue 1.1% · Profit 14.4% · Operating margin change 1.5 points · 83% evidence Capital efficiency 16.8/25 · ROCE 17.3% · Operating margin 10.9% · 76% evidence Valuation 10.9/20 · P/E 16.4× · PEG 1.1 · 65% evidence Relative strength 7.0/20 · Lead over its industry -15.8% · Lead over S&P 500 -21.6% · 1 year -36.3% · 100% evidence · 0 of 12 weeks ahead Exact sum: 17 + 16.8 + 10.9 + 7 = 51.7 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 9. [Freshpet, Inc.](https://www.sectoralpha.in/us/stocks/frpt) FRPT · breaking out · Evidence leans up · 81% evidence 51.3 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 24.3/35 · Revenue 12.8% · Profit 100% · Operating margin change 0.3 points · 83% evidence Capital efficiency 4.9/25 · ROCE 5.6% · Operating margin 7.1% · 76% evidence Valuation 5.7/20 · P/E 14.3× · PEG 2.68 · 65% evidence Relative strength 16.4/20 · Lead over its industry 11.6% · Lead over S&P 500 4.8% · 1 year 26% · 100% evidence · 10 of 12 weeks ahead Exact sum: 24.3 + 4.9 + 5.7 + 16.4 = 51.3 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 10. [Smithfield Foods, Inc.](https://www.sectoralpha.in/us/stocks/sfd) SFD · basing · Evidence leans up · 81% evidence 50.6 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 21.4/35 · Revenue 4.3% · Profit 15.8% · Operating margin change 0.4 points · 83% evidence Capital efficiency 13.4/25 · ROCE 13.5% · Operating margin 8.4% · 76% evidence Valuation 14.5/20 · P/E 9.3× · PEG 0.67 · 65% evidence Relative strength 1.3/20 · Lead over its industry -21.6% · Lead over S&P 500 -26.1% · 1 year -15.9% · 100% evidence · 0 of 12 weeks ahead Exact sum: 21.4 + 13.4 + 14.5 + 1.3 = 50.6 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 11. [BellRing Brands, Inc.](https://www.sectoralpha.in/us/stocks/brbr) BRBR · basing · Evidence leans up · 81% evidence 50.5 out of 100 Growth Capital Valuation Relative
12. [Lamb Weston Holdings, Inc.](https://www.sectoralpha.in/us/stocks/lw) LW · turning · Evidence leans down · 85% evidence 49.9 out of 100 Growth Capital Valuation Relative
13. [Darling Ingredients Inc.](https://www.sectoralpha.in/us/stocks/dar) DAR · quiet · Too little evidence to rank firmly · 58% evidence 49.4 out of 100 Growth Capital Valuation Relative
14. [Ingredion Incorporated](https://www.sectoralpha.in/us/stocks/ingr) INGR · basing · Evidence leans down · 81% evidence 47.7 out of 100 Growth Capital Valuation Relative
15. John B. Sanfilippo & Son, Inc. this page JBSS · quiet · Evidence leans down · 81% evidence 46.3 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 16.1/35 · Revenue 6.2% · Profit 3.3% · Operating margin change -3.1 points · 83% evidence Capital efficiency 16.4/25 · ROCE 17.4% · Operating margin 4.1% · 76% evidence Valuation 13.5/20 · P/E 16× · PEG 0.65 · 65% evidence Relative strength 0.3/20 · Lead over its industry -29.7% · Lead over S&P 500 -33.8% · 1 year -22.2% · 100% evidence · 0 of 12 weeks ahead Exact sum: 16.1 + 16.4 + 13.5 + 0.3 = 46.3 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 16. [General Mills, Inc.](https://www.sectoralpha.in/us/stocks/gis) GIS · basing · Evidence leans down · 75% evidence 45.6 out of 100 Growth Capital Valuation Relative
17. [The Kraft Heinz Company](https://www.sectoralpha.in/us/stocks/khc) KHC · basing · Evidence leans down · 64% evidence 45.2 out of 100 Growth Capital Valuation Relative
18. [The Campbell's Company](https://www.sectoralpha.in/us/stocks/cpb) CPB · basing · Evidence leans down · 85% evidence 43.4 out of 100 Growth Capital Valuation Relative
19. [Post Holdings, Inc.](https://www.sectoralpha.in/us/stocks/post) POST · turning · Evidence leans down · 81% evidence 42.9 out of 100 Growth Capital Valuation Relative
20. [J&J Snack Foods Corp.](https://www.sectoralpha.in/us/stocks/jjsf) JJSF · quiet · Evidence leans down · 81% evidence 41.7 out of 100 Growth Capital Valuation Relative
21. [Pilgrim's Pride Corporation](https://www.sectoralpha.in/us/stocks/ppc) PPC · turning · Evidence leans down · 81% evidence 41.6 out of 100 Growth Capital Valuation Relative
22. [Hormel Foods Corporation](https://www.sectoralpha.in/us/stocks/hrl) HRL · basing · Evidence leans down · 75% evidence 41.4 out of 100 Growth Capital Valuation Relative
23. [Conagra Brands, Inc.](https://www.sectoralpha.in/us/stocks/cag) CAG · basing · Evidence leans down · 75% evidence 40.3 out of 100 Growth Capital Valuation Relative
24. [Flowers Foods, Inc.](https://www.sectoralpha.in/us/stocks/flo) FLO · basing · Too little evidence to rank firmly · 58% evidence 40.3 out of 100 Growth Capital Valuation Relative
25. [JBS N.V.](https://www.sectoralpha.in/us/stocks/jbs) JBS · quiet · Evidence leans down · 81% evidence 40.0 out of 100 Growth Capital Valuation Relative
26. [The Simply Good Foods Company](https://www.sectoralpha.in/us/stocks/smpl) SMPL · turning · Evidence leans down · 71% evidence 39.0 out of 100 Growth Capital Valuation Relative
27. [Utz Brands, Inc.](https://www.sectoralpha.in/us/stocks/utz) UTZ · losing its lead · Evidence leans down · 71% evidence 37.6 out of 100 Growth Capital Valuation Relative
28. [Mama's Creations, Inc.](https://www.sectoralpha.in/us/stocks/mama) MAMA · quiet · Evidence leans down · 85% evidence 37.2 out of 100 Growth Capital Valuation Relative
29. [The Magnum Ice Cream Company N.V.](https://www.sectoralpha.in/us/stocks/micc) MICC · turning · Too little evidence to rank firmly · 31% evidence 51.5 out of 100 Growth Capital Valuation Relative
30. [Once Upon A Farm, PBC](https://www.sectoralpha.in/us/stocks/ofrm) OFRM · quiet · Too little evidence to rank firmly · 41% evidence 41.5 out of 100 Growth Capital Valuation Relative

Missing figures are not scored as bad. They lower the confidence and pull the final score toward the middle. Relative strength counts only when the company has a reading for this week; with no reading, that factor is left out and its 20 points are shared across the other three in proportion. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led S&P 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step path the industry is placed on (basing, turning, breaking out, leader, fading, asleep), read from how many weeks running it has led S&P 500 and whether that lead is growing or shrinking. It describes where the share price stands, not the direction of earnings, and it is not a recommendation; it is left blank for a company whose weekly history is too short or too stale to read. The figures in this ranking come from the industry comparison: results through the Sep 2026 quarter, and the P/E at that quarter's end. The sections above use the latest weekly price, so a P/E or return there can differ a little from the one here. The stage words in this ranking (such as losing its lead or breaking out) describe the lead over the index, not the price phase in the price section. Related companies: [Packaged Foods](https://www.sectoralpha.in/us/sectors/packaged-foods), all 30 compared on one page. ## Which companies are close to John B. Sanfilippo & Son in size? John B. Sanfilippo & Son is the 29th largest of 39 Packaged Foods companies on Sector Alpha by market value (scores of 3 November 2026). Just above it: Seneca Foods Corporation, Seneca Foods Corporation and Westrock Coffee Company. Just below it: Mama's Creations, Inc., Once Upon A Farm, PBC and Lifeway Foods, Inc. ### Packaged Foods companies close in size

1. [Seneca Foods Corporation](https://www.sectoralpha.in/us/stocks/senea) $1 billion
2. [Seneca Foods Corporation](https://www.sectoralpha.in/us/stocks/seneb) $1 billion
3. [Westrock Coffee Company](https://www.sectoralpha.in/us/stocks/west) $925 million
4. John B. Sanfilippo & Son, Inc. $615 million
5. [Mama's Creations, Inc.](https://www.sectoralpha.in/us/stocks/mama) $607 million
6. [Once Upon A Farm, PBC](https://www.sectoralpha.in/us/stocks/ofrm) $400 million
7. [Lifeway Foods, Inc.](https://www.sectoralpha.in/us/stocks/lway) $336 million

[All 39 Packaged Foods companies, largest first](https://www.sectoralpha.in/us/sectors/packaged-foods#all-companies)

### Companies close in size in other industries

1. [Five Point Holdings, LLC](https://www.sectoralpha.in/us/stocks/fph) $631 million · Real Estate - Development
2. [Gold Royalty Corp.](https://www.sectoralpha.in/us/stocks/groy) $630 million · Gold
3. John B. Sanfilippo & Son, Inc. $630 million
4. [Kimball Electronics, Inc.](https://www.sectoralpha.in/us/stocks/ke) $629 million · Electrical Equipment & Parts
5. [4D Molecular Therapeutics, Inc.](https://www.sectoralpha.in/us/stocks/fdmt) $628 million · Biotechnology

## What else do people ask about John B. Sanfilippo & Son? ### What were John B. Sanfilippo & Son's latest quarterly results? John B. Sanfilippo & Son, Inc. reported revenue of $280 M and net profit of $8.4 M for the Jun 2026 quarter. Revenue rose 4.2% and profit fell 37.9% compared with a year earlier. Earnings per share were $0.71 (as of 3 November 2026). ### What is John B. Sanfilippo & Son's market cap? John B. Sanfilippo & Son, Inc.'s market capitalisation is $615 M at a stock price of $52.59. Market cap is the share price times the number of shares, so it changes whenever the price moves (as of 3 November 2026). ### How is John B. Sanfilippo & Son performing? John B. Sanfilippo & Son, Inc.'s latest readings are below. In its latest quarter, revenue rose 4.2% and profit fell 37.9% compared with a year earlier. Over the past 13 weeks it has done worse than the S&P 500, for 12 weeks running (as of 3 November 2026). ### Will John B. Sanfilippo & Son's stock price go up? This page does not forecast John B. Sanfilippo & Son, Inc.'s stock price. What it shows instead: the stock price is $52.59. Its P/E of 11.0× is higher than 7% of its own last 1 years (as of 3 November 2026). ### Does John B. Sanfilippo & Son have too much debt? John B. Sanfilippo & Son, Inc. has a moderate amount of debt: its debt is 0.40× its equity. A year-by-year history of its borrowings is not in our data, so this uses the latest reading. Keep that borrowing in mind when reading the returns on this page (as of 3 November 2026). ### Where is John B. Sanfilippo & Son in its business cycle? John B. Sanfilippo & Son, Inc.'s FY26 operating margin was 7.3%, against a 6-year range of 7.3% to 9.9%: the low end of its own range, which is often where recoveries start. The latest quarter was 4.1%. Comparing margins with a company's own long history is a good way to see where it is in its cycle (as of 3 November 2026). ### What could break the John B. Sanfilippo & Son story? The main question: the P/E is near the low end of its own history, higher than only 7% of past readings, but results are getting worse. A low multiple can stay low until the quarters turn. On price, this page treats a rise as over when the share price closes below its 200-day average on two Fridays in a row (as of 3 November 2026). ### Is John B. Sanfilippo & Son a stock worth studying right now? What the numbers show: John B. Sanfilippo & Son, Inc.'s P/E is near the low end of its own history, higher than only 7% of past readings, and its quarterly results are still getting worse. The main open question: whether results start to improve. Every number on this page is worked out by code from the published figures, with no forecasts and no price opinions (as of 3 November 2026). This is research, not advice. We’re not SEBI-registered.